FP0391 Confidence, Glucosamine Plus, With Hyaluronic Acid + Curcumin & Boswellia, 60 Extended Release Tablets
Recalling firm: Confidence Inc./Confidence U.S.A. Inc.
Why it was recalled
Product contains undeclared ingredients, Hydroxypropyl Methylcellulose (HPMC), Titanium Dioxide, Polyethylene Glycol (PEG), Triacetin.
Check your package
Compare the exact product and package details with the label you have.
ProductFP0391 Confidence, Glucosamine Plus, With Hyaluronic Acid + Curcumin & Boswellia, 60 Extended Release Tablets, UPC: 8 92483 00106 9
UPC892483001069
FDA code information
Lot# 030616
Match the product, package size, and code together. A missing match does not guarantee safety.
Full FDA record and distribution details
Original product description
FP0391 Confidence, Glucosamine Plus, With Hyaluronic Acid + Curcumin & Boswellia, 60 Extended Release Tablets, UPC: 8 92483 00106 9
Extracted codes and context
| Type | Code / value | Context |
|---|---|---|
| UPC | 892483001069 | With Hyaluronic Acid + Curcumin & Boswellia, 60 Extended Release Tablets, UPC: 8 92483 00106 9 |
| lot | 030616 | Lot# 030616 |
Recall details
- Recall number
- F-1816-2018
- Event ID
- 80620
- FDA status
- Terminated
- Initiated
- Jul 26, 2018
- Reported
- Aug 22, 2018
- Classified
- Aug 13, 2018
- Terminated
- Oct 22, 2019
- Quantity
- 5,650 bottles in US distribution (total for all products)
- Location
- Port Washington, NY, United States
- Initiation type
- Voluntary: Firm initiated
- Notification
- Letter
Where it was distributed
Nationwide
FDA source record · F-1816-2018
Data updated September 16, 2026. View official FDA data ↗
Follow official FDA and manufacturer guidance.